Company intelligence / Profile preview

KM Pathogen Defense

Jupiter, Florida, United States

Ownership: Private
Development stage: Other

Overview

KM Pathogen Defense is a biotechnology and medical technology company focused on developing advanced solutions to mitigate the spread of airborne and surface-borne pathogens. The company's primary offering is a proprietary pathogen defense system designed to neutralize viruses, bacteria, and fungi in high-traffic environments. Their technology utilizes specialized antimicrobial coatings and air purification mechanisms to provide continuous protection against infectious diseases such as COVID-19 and influenza. KM Pathogen Defense aims to enhance public health safety in commercial, healthcare, and residential settings through scientifically validated decontamination protocols.

Therapeutic areas: Infectious Diseases
Modalities: DeviceAntiviral
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on KM Pathogen Defense.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on KM Pathogen Defense.

Explore the full profile